{
    "title": "US FDA staff flag 'serious' safety risks for Intercept's NASH treatment (May 17)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12094377/US-FDA-staff-flag-safety-risks-Intercepts-NASH-treatment.html",
    "date": "2023-05-17",
    "keywords": [
        "treatment",
        "oca",
        "drug",
        "fda",
        "roy",
        "staff",
        "disease",
        "risk",
        "injury",
        "liver",
        "inc",
        "health",
        "wednesday",
        "string",
        "type",
        "food",
        "acid",
        "steatohepatitis",
        "meeting",
        "friday",
        "nash",
        "therapy",
        "companys",
        "marketing",
        "application",
        "effectiveness",
        "brand",
        "name",
        "ocaliva",
        "cholangitis",
        "usage",
        "cirrhosis",
        "sludge",
        "formation",
        "gall",
        "bladder",
        "imbalance",
        "course",
        "review",
        "mg",
        "dose",
        "superiority",
        "reduction",
        "scarring",
        "uncertainty",
        "population",
        "eligible",
        "nordisk",
        "akero",
        "multibillion",
        "dollar",
        "market",
        "reporting",
        "leroy",
        "leo",
        "bengaluru",
        "editing",
        "rashmi",
        "aich",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}